Epidemiology of restless legs syndrome as diagnosed in UK primary care

Sleep Medicine
David A M C Van De VijverHans Petri

Abstract

Restless legs syndrome (RLS) is a sensorimotor disorder with a general-population prevalence of 5-10%. Although, data on the prevalence of clinically diagnosed RLS are limited, and there are none regarding incidence, a shortfall compared with general-population values is likely, as not all patients are driven to consult. There may also be poor awareness of the condition among primary care physicians (PCPs). The General Practice Research Database was used to gather prevalence and incidence data from UK PCPs and to investigate PCP awareness over the period 1994-1998. A total of 1,561,692 persons were covered by the database on January 1, 1999. A diagnosis of RLS was registered in 3877 patients, giving a prevalence of 0.25%. Incidence values were also low (41.0 per 100,000 person-years), increased with age and were higher in women than in men. Although, at least one RLS diagnosis was made in 94% of medium-to-large practices, sufferers were more likely than age/sex-matched controls to be diagnosed with conditions commonly confused with RLS in 2 years before receiving their RLS diagnosis. Furthermore, at the time of diagnosis, many sufferers were prescribed medications not effective in RLS (principally, oxerutins and quinine). These...Continue Reading

References

May 1, 1994·Age and Ageing·S T O'KeeffeJ N Lavan
Sep 1, 1995·Movement Disorders : Official Journal of the Movement Disorder Society·A S Walters
Jan 1, 1997·Movement Disorders : Official Journal of the Movement Disorder Society·J MontplaisirP Lespérance
Oct 29, 2000·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J MontplaisirD Petit
Jul 4, 2001·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·R P Allen, C J Earley
Jul 11, 2001·Journal of Women's Health & Gender-based Medicine·K A LeeK Baratte-Beebe
Dec 19, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·J UlfbergC Edling
Mar 23, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·F Gemignani, A Marbini
Jul 11, 2002·Pharmacopsychiatry·T C WetterT Bronisch
Jul 20, 2002·Journal of Psychosomatic Research·Maurice M Ohayon, Thomas Roth
Oct 3, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Juliane WinkelmannClaudia Trenkwalder
May 23, 2003·The New England Journal of Medicine·Christopher J Earley

❮ Previous
Next ❯

Citations

Sep 15, 2009·Journal of Circadian Rhythms·Akbar SharifianAli Fardi
Mar 1, 2011·BMC Neurology·Diego Garcia-BorregueroMarco Zucconi
Nov 1, 2012·Acta neurologica Belgica·Nesrin Helvaci YilmazOzlem Aykac
May 16, 2009·Journal of Neurology·Claudia TrenkwalderJuliane Winkelmann
Oct 1, 2007·Expert Review of Pharmacoeconomics & Outcomes Research·Jens P ReeseRichard C Dodel
Apr 18, 2009·Expert Review of Pharmacoeconomics & Outcomes Research·András SzentkirályiMárta Novák
Sep 18, 2008·Current Medical Research and Opinion·M LeesUNKNOWN RLS Health Economic Study Group
Apr 7, 2009·Revue neurologique·I Ghorayeb, F Tison
Apr 7, 2009·Parkinsonism & Related Disorders·Yoshio TsuboiTatsuo Yamada
Mar 18, 2008·Clinical Therapeutics·Carlos MartinezAnthony H V Schapira
Nov 21, 2007·Sleep Medicine·Daniel L Picchietti, Hanna E Stevens
Oct 9, 2007·Sleep Medicine·Imad GhorayebFrançois Tison
Jun 16, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Ilana SchlesingerDavid Yarnitsky
Oct 25, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·G M HadjigeorgiouE Zintzaras
Jul 29, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Jacques MontplaisirDieter Volc
Jul 17, 2013·Journal of Midwifery & Women's Health·Priscilla M Nodine, Ellyn E Matthews
Jun 10, 2006·Sleep Medicine Reviews·Diego Garcia-BorregueroKlaus Berger
Nov 23, 2005·Progress in Neurobiology·G BarrièreI Ghorayeb
May 21, 2015·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Sibel GülerYahya Çelik
Oct 27, 2005·Diabetes Care·Lívia A LopesVeralice M S de Bruin
Sep 25, 2007·Cephalalgia : an International Journal of Headache·A M RhodeS Evers
Oct 22, 2010·São Paulo Medical Journal = Revista Paulista De Medicina·Emmanouil SymvoulakisChristos Lionis
Nov 26, 2008·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·N C V MoreiraV M S de Bruin
Feb 7, 2018·Avicenna Journal of Medicine·Mohmd KhanHamdan Al-Jahdali
Apr 23, 2005·The Cochrane Database of Systematic Reviews·R G BarrF S F Ram
Mar 29, 2014·The Cochrane Database of Systematic Reviews·Kayleigh M KewChristopher J Cates
Jul 22, 2014·The Cochrane Database of Systematic Reviews·Charlotta KarnerPhillippa Poole
Jul 9, 2005·Current Opinion in Neurology·Birgit Högl, Werner Poewe
Dec 31, 2016·Digestive Diseases and Sciences·Ikuko TakaharaKazuhiko Nakao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here